시상안내 행사참여하기 수상특전 보도자료
수상 특전
전 세계(언어권 별로 속해 있는 언론매체에 게재) 영어권 수상 특전 (합의된 브랜드에 한함) 영어권 국가 전 세계 약 28억
영문 뉴스 전 세계 영어권 300개 이내 언론 매체를 통해 수상 브랜드 노출 (사진 2~3매)
영문 동영상 영문 뉴스에 1개의 동영상을 첨부할 수 있으며 영어권 다수 매체에 해당 됩니다.
동영상 게재를 원하는 기업 및 기관은 영문 기반의 동영상(홍보영상 또는 CF 등)을 보내주시기 바랍니다.
국가명 지역명
북아메리카 미국, 캐나다
남아메리카 바베이도스, 벨리즈, 도미니카공화국, 그레나다, 가이아나, 자메이카, 세인트키츠네비스, 세인트루시아, 세인트빈센트그레나딘, 시에라리온, 트리니다드토바고, 바하마, 앤티카바부다
유럽 영국, 아일랜드, 몰타
아프리카 남아프리카공화국, 잠비아, 잠바브웨, 시에라리온, 라이베리아, 보츠와나, 카메룬, 에리트레아, 에티오피아, 감비아, 가나, 케냐, 레소토, 말라위, 모리셔스, 나미비아, 나이지리아, 르완다, 세이셸, 남수단, 수단, 스와질란드, 우간다, 탄자니아
아시아 인도, 파키스탄, 싱가폴, 필리핀, 말레이시아, 홍콩, 브루나이, 스리랑카
중동 레바논, 바레인
오세아니아 호주, 뉴질랜드, 파퓨아 뉴기니, 피지, 키리바시, 미크로네시아연방, 나우루, 팔라우, 파푸아뉴기니, 사모아, 솔로몬제도, 통가, 투발루, 바누아투, 마셜제도

  • 영어권 300개 이내 뉴스 사이트 노출
    • 지역별, 산업별, TV & RADIO 매체를 포함한 300개 이내 뉴스 사이트에 게재
  • 방대한 글로벌 네트워크
    • 세계적인 미디어 아울렛과 톱뉴스 사이트들을 중심으로 한 영어권 글로벌 네트워크 확보
    • 구글 뉴스를 통해 CBS, FOX, ABC 등 해외 주요 방송사 사이트 및 프리미엄 뉴스 아울렛에 배포
  • 해외 검색 엔진 최적화
    • 구글 닷컴 뉴스로 게재되어 관련 키워드 검색 시 구글(모든 국가 공통) 뉴스 카테고리 노출
  • 파이널 리포트 제공
    • 기사 링크 및 구글 뉴스 노출 스크린 샷을 포함한 스마트 리포트 제공
2021 전반기 영문 뉴스와 동영상 노출 사례(영어권 301개 언론사에 게재 됨)

Novomics developed the world's first molecular diagnostic assay, nProfiler® 1 Stomach Cancer Assay

Monday, June 21st 2021, 1:14 PM PDT

Novomics is a biomedical science company, leading the development of diagnosis system for the linkage of cancer and treatment on the basis of our specialized technology and knowledge in molecular diagnostics.

Novomics is a biomedical science company, leading the development of diagnosis system for the linkage of cancer and treatment on the basis of our specialized technology and knowledge in molecular diagnostics.

Novomics developed the world’s first molecular diagnostic assay, nProfiler® 1 Stomach Cancer Assay, for post-operative prediction in stomach cancer. The nProfiler® 1 Stomach Cancer Assay is the first-in-clinical molecular IVD test, which measures gene-expression levels in FFPE gastric tumor tissues with real-time RT-PCR to predict the prognosis and chemotherapy response after D2 surgery for stage II-III gastric cancer. This technology has been validated with the archived samples of CLASSIC trial whose results had been updated in the standard treatment guideline for gastric cancer patients. The gene expression-based nProfiler® 1 Stomach Cancer Assay stratifies patients with gastric cancer according to risk parameters (Low risk, Intermediate risk, High risk) after D2 gastrectomy. (Lancet Oncol 2018; 19: 629-38).
Clinically, the nProfiler® 1 provides clinicians with auxiliary information distinct from the standard risk-stratification methods, such as TNM staging and histological grade, which might be useful when making decisions about adjuvant therapy after D2 surgery for patients with stage II-III gastric cancer.

Novomics is under commercialization process of nProfiler® series including nProfiler® 1 to actualize the vision “For Better Life”. Novomics puts all the investments and efforts in R&D and approval process using accumulated knowledge from medical industry for cancer patients. Throughout all the process, Novomics enhances its value and promise to put its utmost efforts with internal and external supports to get an ordinary everyday life to cancer patients.

– Reporter: Yoon Kwang-hee
Sources: www.hksisaeconomy.com

- Media : Contact
- Company Name:Novomics
- Contact Person:Media Relations
- Email: Send Email
- Phone: +82-2-2068-3700(6868)
- Country: South Korea
- Website: www.novomics.com


※ 아래 매체 별 로고를 클릭하면 보도 기사를 확인할 수 있습니다.
※ 각 언론사의 성향에 따라 기사 노출 기간이 상이합니다.
2019 영문 뉴스와 동영상 노출 사례(영어권 315개 언론사에 게재 됨)

Haimbio, a high tech R&D bio firm, awarded for Cancer Energy Metabolism-based Therapy (CEMBT's) by Korean National Assembly

Posted: Jan 15, 2020 5:41 AM

Haimbio (Ph. D. Hong Yeoul Kim, CEO), a research and development bio firm has recently received the Award by the head of Health and Welfare Committee in Korean National Assembly and the 3rd Global Power Brand Award.

Starvanip® has a rather unique and universal technology platform oriented for new paradigm of anti-cancer drug.  This differentiates from existing anti-cancer drugs by the effects; i.e., — inhibiting the generation of Cancer Energy source, so inducing the apoptosis, the death of cancer cell.  In doing so, this is anticipated to dramatically improve the side effects such as damaging normal cell and to further reduce toxicity accompanied by existing anti-cancer therapies.  Last but not the least, the firm insists to augment the low rate of curing and to target wider range of cancer types.

With the tests on not only animals but also patient derived cells and organoid, the pre-clinical efficacy and safety have been secured.  In duration of this pre-clinical phase, the firm has tested and confirmed the significant efficacy by combined use of Starvanip® with the conventional anti-cancer drugs for the indications of 12 different types of cancer, including GBM, pancreatic cancer, non-small cell cancer, and etc.

Beginning from early Dec. of 2019, the firm has Starvanip® at the stage of Clinical Trial Phase 1 in Korea which is targeted exclusively on 40 + patients who have failed the conventional anti-cancer therapies.  Simultaneously, the firm is in the preparation of pre-IND scheduled early part of 2020 and Clinical Trial Phase 2 in USA to be filed later part of this year.  Ultimately, the firm is aiming at Orphan Disease Designation (ODD) which will make the path to the conditional sales of Starvanip® after the completion of Clinical Trial Phase 2 in USA.

Starvanip® is the anti-cancer substance in-licensed from Korea’s National Cancer Center (NCC) and Yonsei Medical Center has been intensively proceeded for the indications of the variety of cancer. Reporter at Korean sisa economy: Yoon Kwang Hee   Sources: www.hksisaeconomy.com

- Media : Contact
- Name:Haim Bio Co., Ltd.
- Contact Person:Media Relations
- Email: Send Email
- Phone: +82-70-5057-5004
- Country: South Korea
- Website: www.haimbio.com


※ 아래 매체 별 로고를 클릭하면 보도 기사를 확인할 수 있습니다.
※ 각 언론사의 성향에 따라 기사 노출 기간이 상이합니다.
2018 영문 뉴스와 동영상 노출 사례(영어권 302개 언론사에 게재 됨)

[2018 Global Power Brand Award] BULLS CO., Ltd, the front runner of machinizing crop-cultivation, proved their quality by exporting to Australia·Japan

By: Get News                                                             April 08, 2019 at 15:30 PM EDT

BULLS which leads plot cultivating machine industry is doing their best to solve lack of man power in rural areas and to help improve income of farmhouse. After founded on 2000, they became truely a front runner of crop-cultivation machinizing by contriving·manufacturing various plot cultivating machines such as multi-purpose loop molding machine · vinyle coating machine · seeding machine on tractor · pest control device · underground plant harvesters · trunk cutting machine and etc. Based on its outstanding technology, BULLS has been recognized of its fine quality while exporting products world wide to countries of Austrailia · Japan · Italy · China · Kazakhstan and others.

According to the data provided by Ministry of Agriculture, Food and Rural Affairs, domestic rice farming machinization rate is 97.9%. Compared to this, plot farming machinization rate ended up just upto 58.3%. Among them, machinization of seeding and operation 8.9%, harvesting on 23.9%.

The government plans to increase plot machinization rate upto 75% by 2022 using 4000 hundred million. To catch up with the plan, BULLS focused on seeding and harvesting related agricultural machine investigation and development. This year Rural Developlement Administration(RDA) appointed 3 models of powered seeding machine and 2 models of underground plant harvester as New Technology Agriculture Machine(NET), acknowledging BULLS’ fine quality and technology. Young Jo Nam, CEO of BULLS stated “We will do our best on quality improvement and research and investigaion to supply the product that farmer really want.”

– Oh Noo Ri, Reporter at Chosun Ilbo


- Media : ContactCompany
- Name: BULLS CO., Ltd.
- Contact Person: Media Relations
- Email: Send Email
- Phone: +82-54-954-2810
- Country: South Korea
- Website: www.ibulls.co.kr



※ 아래 매체 별 로고를 클릭하면 보도 기사를 확인할 수 있습니다.
※ 각 언론사의 성향에 따라 기사 노출 기간이 상이합니다.
2017 영문 뉴스와 동영상 노출 사례(영어권 516개 언론사에 게재 됨)

[2017 Global Power Brand Award] Lotte World Seoul Sky 555m high-rise observatory

Posted: Dec 27, 2017 2:59 AM

‘Fabulous’ scenery spreading under the feet

Lotte World’s Seoul Sky Co., Ltd. won the 2017 Global Power Brand Award(GPBA) and the Award of “Yoo Sung-yeop, the Chairman of the Education, Culture, Sports and Tourism Committee at the National Assembly”. Seoul Sky is the observatory facility located on the top floor of 123-story, 555m-high Lotte World Tower. To enjoy the observatory facilities, take the double deck elevator sky shuttle from the entry level. A double deck elevator is a type in which two elevators are operated vertically. The Sky Shuttle that operating at a speed of 600m at a section of 496m(from the second basement to the 121st floors), has a name on the Guinness World Record for the following two items: the longest traffic distance and the fastest double deck elevator. If you go up to the 500-meter-high viewing floor, you can enjoy a 360-degree view of Seoul, the capital of Korea, at a glance. On sunny days, the visibility reaches up to 40 km, allowing visitors to see Songdo and the West Sea of Incheon. The Skydeck, located on the 118th floor (478m above the ground), offers a different view. It is designed to walk on clear glass floors and feels like walking on the sky. It was listed on Guinness World Records as the highest glass floor observatory. At Sky Terrace on the 120th floor, you can enjoy a different pleasure by enjoying the scenery of the outdoors rather than seeing the panorama through the window. If you feel hungry, you can go to the 123rd floor, the top of the observatory: “123 lounge”, the premium lounge is available. The 123 lounge operates as a café during the afternoon offering teas and desserts, and transforms into a lounge offering wine and beer in the evening when the sun sets over the sky. It can also be used for corporate events and wedding ceremonies. Seoul Sky will keep the number of visitors at an appropriate level in order to maintain a safe and pleasant viewing environment. In addition, an airport-level security check is underway to enhance security. Security guards and CCTVs are installed throughout the observatory to ensure safe outings. An official of Lotte World Seoul Sky said, "You can enjoy various exhibitions, performances and experiences, not just looking at the surrounding scenery like other conventional observatories. We will grow into a place that will let tourists visiting Korea come to see the most beautiful Seoul." For further information, visit Lotte World Seoul Sky website (seoulsky.lotteworld.com). - Chosun Ilbo Reporter: Ha Ji Soo


- Media : ContactCompany
- Name: Lotte World Seoul Sky Co., Ltd
- Contact Person: Lotte World Seoul Sky Global Team
- Email: seoulsky@lotte.net
- Phone: +82-1661-2000
- Country: South Korea
- Website: seoulsky.lotteworld.com



※ 아래 매체 별 로고를 클릭하면 보도 기사를 확인할 수 있습니다.
※ 각 언론사의 성향에 따라 기사 노출 기간이 상이합니다.